Long term survival and perioperative propensity score matched outcomes in diaphragmatic interventions in cytoreductive surgery plus intra-peritoneal chemotherapy

被引:3
作者
Singh, Bhavneet [1 ]
Singh, Gurkirat [1 ]
Alzahrani, Nayef [1 ,2 ,3 ]
Arrowaili, Arief [3 ]
Morris, David L. [1 ,2 ]
机构
[1] St George Hosp, Peritonect & Liver Unit, Kogarah, NSW, Australia
[2] Univ New South Wales, Med, St George Clin Sch, Sydney, NSW, Australia
[3] Al Imam Mohammad Ibn Saud Islamic Univ, Riyadh, Saudi Arabia
来源
EJSO | 2019年 / 45卷 / 04期
关键词
Cytoreductive; Intraperitoneal chemotherapy; Diaphragm; LAMNs and colorectal; HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; SYSTEMIC CHEMOTHERAPY; OVARIAN-CANCER; CLASSIFICATION; DIAGNOSIS;
D O I
10.1016/j.ejso.2018.12.021
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives: To assess the impact of short and long term outcomes of diaphragmatic interventions in cytoreductive surgery (CRS) and intra-peritoneal chemotherapy (IPC). Methods: 1230 consecutive CRS/IPC procedures were preformed between 1996 and 2018 in Sydney, Australia. Redo procedures and incomplete cyto-reductions were excluded. Among these, 599 underwent diaphragmatic intervention. Preoperative heterogeneity was assessed for in 6 parameters and addressed with propensity score matching. CRS/IPC requiring diaphragmatic interventions were compared to CRS/IPC without diaphragmatic involvement. Ten perioperative outcomes were measured. Overall survival was assessed based on diagnosis type. Results: Intraoperative results revealed a significant increase in operative hours (7.85 vs. 7.28, p = 0.033). Transfusion requirements were insignificantly different. Postoperatively, increased grade III and IV complications (36% vs. 26%, p = 0.052) were noted. There was no difference with regards to intensive care stay, hospital length of stay, hospital death and return to theatre. In terms of respiratory specific complications, an increased incidence of pneumothorax (13% vs. 3%, p = 0.001) and pleural effusions (24% vs. 16%, p = 0.043) were noted, whilst the differences in pneumonia were insignificant. Overall survival revealed diaphragm interventions; did not affect survival outcomes in colorectal cancers (p = 0.750, RR = 1.077, CI 0.683-1.697) and increased relative risk in low-grade appendiceal mucinous neoplasms (p = 0.025, RR = 2.437, CI 1.121-5.298). Conclusion: After our three-tiered research strategy, we conclude that despite the marginal increase in short term morbidity; diaphragmatic interventions do not decrease survival in colorectal cancers and diaphragmatic disease in LAMNs maybe an independent prognosticator of disease aggression. Crown Copyright (C) 2018 Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:620 / 624
页数:5
相关论文
共 14 条
[1]   The histopathological classification, diagnosis and differential diagnosis of mucinous appendiceal neoplasms, appendiceal adenocarcinomas and pseudomyxoma peritonei [J].
Carr, Norman J. ;
Bibeau, Frederic ;
Bradley, Robert F. ;
Dartigues, Peggy ;
Feakins, Roger M. ;
Geisinger, Kim R. ;
Gui, Xianyong ;
Isaac, Sylvie ;
Milione, Massimo ;
Misdraji, Joseph ;
Pai, Reetesh K. ;
Rodriguez-Justo, Manuel ;
Sobin, Leslie H. ;
van Velthuysen, Marie-Louise F. ;
Yantiss, Rhonda K. .
HISTOPATHOLOGY, 2017, 71 (06) :847-858
[2]   Cytoreductive surgery and intraperitoneal chemotherapy versus systemic chemotherapy for colorectal peritoneal metastases: A randomised trial [J].
Cashin, P. H. ;
Mahteme, H. ;
Spang, N. ;
Syk, I. ;
Frodin, J. E. ;
Torkzad, M. ;
Glimelius, B. ;
Graf, W. .
EUROPEAN JOURNAL OF CANCER, 2016, 53 :155-162
[3]   Early- and Long-Term Outcome Data of Patients With Pseudomyxoma Peritonei From Appendiceal Origin Treated by a Strategy of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy [J].
Chua, Terence C. ;
Moran, Brendan J. ;
Sugarbaker, Paul H. ;
Levine, Edward A. ;
Glehen, Olivier ;
Gilly, Francois N. ;
Baratti, Dario ;
Deraco, Marcello ;
Elias, Dominique ;
Sardi, Armando ;
Liauw, Winston ;
Yan, Tristan D. ;
Barrios, Pedro ;
Gomez Portilla, Alberto ;
de Hingh, Ignace H. J. T. ;
Ceelen, Wim P. ;
Pelz, Joerg O. ;
Piso, Pompiliu ;
Gonzalez-Moreno, Santiago ;
Van der Speeten, Kurt ;
Morris, David L. .
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (20) :2449-2456
[4]   Morbidity and Mortality Outcomes of Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy at a Single Tertiary Institution Towards a New Perspective of This Treatment [J].
Chua, Terence C. ;
Saxena, Akshat ;
Schellekens, J. F. ;
Liauw, Winston ;
Yan, Tristan D. ;
Fransi, Sal ;
Zhao, Jing ;
Morris, David L. .
ANNALS OF SURGERY, 2010, 251 (01) :101-106
[5]   Classification of surgical complications - A new proposal with evaluation in a cohort of 6336 patients and results of a survey [J].
Dindo, D ;
Demartines, N ;
Clavien, PA .
ANNALS OF SURGERY, 2004, 240 (02) :205-213
[6]   Intraperitoneal chemotherapy in the first-line treatment of women with stage III epithelial ovarian cancer - A systematic review with melaanalyses [J].
Elit, Laurie ;
Oliver, Thomas K. ;
Covens, Allan ;
Kwon, Janice ;
Fung, Michael -Kee Fung ;
Hirte, Holger W. ;
Oza, Amit M. .
CANCER, 2007, 109 (04) :692-702
[7]   Outcome of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy on Patients with Diaphragmatic Involvement [J].
Franssen, Bernardo ;
Tabrizian, Parissa ;
Weinberg, Alan ;
Romanoff, Anya ;
Tuvin, Daniel ;
Labow, Daniel ;
Sarpel, Umut .
ANNALS OF SURGICAL ONCOLOGY, 2015, 22 (05) :1639-1644
[8]  
Jacquet P, 1996, Cancer Treat Res, V82, P359
[9]   Diaphragmatic Surgery in Advanced Ovarian, Tubal and Peritoneal Cancer. A 7-Year Retrospective Analysis of the Tumor Bank Ovarian Cancer Network [J].
Muallem, Mustafa Zelal ;
Almuheimid, Jumana ;
Richter, Rolf ;
Braicu, Elena Ioana ;
Osman, Suzan ;
Sehouli, Jalid .
ANTICANCER RESEARCH, 2016, 36 (09) :4707-4713
[10]   Hyperthermic intraperitoneal chemoperfusion (HIPEC) decrease wound strength of colonic anastomosis in a rat model [J].
Pelz, J. O. W. ;
Doerfer, J. ;
Decker, M. ;
Dimmler, A. ;
Hohenberger, W. ;
Meyer, T. .
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2007, 22 (08) :941-947